Clinical trial · Observational
Management of Women With BRCA1/2 Mutation
Role of General Practionners in Management of Women With BRCA1/2 Mutation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation. This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| BRCA1 Mutation | — | UNRESOLVED | — |
| BRCA2 Mutation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire given to the two groups | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with BRCA ½ mutation
- description
- Women with BRCA 1 / 2 mutation with or without cancer Age over 18
- interventionNames
- Behavioral: Questionnaire given to the two groups
- label
- GP
- description
- GP of the patients with BRCA 1 / 2 mutation
- interventionNames
- Behavioral: Questionnaire given to the two groups
Primary outcomes (1)
- measure
- The rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation.
- timeFrame
- 1 day
- description
- Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria * Aged over 18 * Women * Living in France * Having a medical insurance Exclusion criteria * Men * Dementia * Non frenchspeaker * Mental retardation * Being the subject of a guardianship or tutelage measure
References
Publications (0)
Data not yet available